Its receptors are assembled from the calcitonin receptor (CTR) core combined with one of three receptor-activity-modifying proteins (RAMP1, RAMP2, or RAMP3), producing the amylin-receptor subtypes designated AMY, AMY, and AMY
177 Similar results were reported for patients with and without Hunner lesions for whom multiple therapeutic hydrodistension with 100 cm H 2 O for 5 minutes, over several years, did not significantly change bladder capacity
The Absorption Problem with L-Arginine Here's the research that changed how most clinicians think about this: a landmark pharmacokinetic study found that oral L-arginine is extensively catabolized by arginase enzymes in the intestinal mucosa and by hepatic first-pass metabolism
This pattern suggests sophisticated regulatory control rather than simple up- or down-regulation
Here's what we've learned working with research-grade peptides: the pharmacodynamic timeline is always longer than the pharmacokinetic timeline for receptor agonists
The results from my summer project are included in this publication: Joshi, V., K
